← Back to Clinical Trials
Recruiting NCT07261358

NCT07261358 The Effect of Three-Dimensional Exercises ( Schroth Method ) on Trunk Muscle Endurance, Sleep Quality, and Quality of Life in Adolescents With Hyperkyphosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07261358
Status Recruiting
Phase
Sponsor Gaziosmanpasa Research and Education Hospital
Condition Spine Deformity
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-10-06
Primary Completion 2026-03-29

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Kyphosis Study FormScoliosis X-ray (Orthoroentgenogram)Inclinometer Measurement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-10-06 with a primary completion date of 2026-03-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Adolescence is a critical period for spinal growth, and progression of thoracic hyperkyphosis may lead to pain, weak trunk muscles, sleep disturbances, and reduced quality of life. This study aims to investigate the effects of three-dimensional exercise program based on the Schroth Method on trunk muscle endurance, thoracic kyphosis angle, pain, sleep quality and quality of life in adolescents aged 12-18 years with hyperkyphosis.

Eligibility Criteria

Inclusion Criteria: * Adolescents between 12 and 18 years of age * Presence of thoracic kyphosis with a T3-T12 Cobb angle ≥45° measured on a lateral thoracic radiograph * Sufficient physical and cognitive ability to actively participate in the exercise protocol for at least 3 months * Adequate communication and cognitive capacity to understand the educational materials provided * Ability and willingness to regularly complete the exercise log throughout the study period Exclusion Criteria: * Scoliosis with a Cobb angle \>10° in the coronal plane * Presence of structural spinal deformities such as vertebral fracture, spondylolisthesis * History of previous spinal surgery * Neuromuscular disorders that may affect the spine (e.g., cerebral palsy, muscular dystrophy) * Structural or functional pathologies involving the spine, pelvic complex, or shoulder girdle * Balance disorders such as vestibular dysfunction, vertigo, or other conditions affecting postural control * Inability to comply with the exercise protocol due to intellectual disability, severe behavioral disorders, or significant communication impairments * Participation in professional-level sports activities that may influence exercise capacity or musculoskeletal function * Presence of serious cardiopulmonary diseases (e.g., congenital heart disease, pulmonary hypertension)

Contact & Investigator

Central Contact

Öznur Molla Kocabaş, MD

✉ oznurmolla@gmail.com

📞 +905388837799

Principal Investigator

Ebru Yılmaz Yalçınkaya, MD,Professor

STUDY DIRECTOR

Gaziosmanpaşa Training and Research Hospital Physical Rehabilitation Department

Frequently Asked Questions

Who can join the NCT07261358 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Spine Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07261358 currently recruiting?

Yes, NCT07261358 is actively recruiting participants. Contact the research team at oznurmolla@gmail.com for enrollment information.

Where is the NCT07261358 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07261358 clinical trial?

NCT07261358 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is Ebru Yılmaz Yalçınkaya, MD,Professor at Gaziosmanpaşa Training and Research Hospital Physical Rehabilitation Department. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology